文献速递冠心病

COVID-19大流行对STEMI患者死亡率影响的系统综述与荟萃分析

Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis.
PubMed 文献 · Heart · 2020-12-17

结果显示疫情期间STEMI入院率显著下降(IRR=0.789,95%CI 0.730-0.852),但院内死亡率无显著差异(OR=1.178,95%CI 0.926-1.498)。症状至首次医疗接触时间相似,而门球时间显著延长(MD=7.3分钟,95%CI 3.0-11.7)。

要点

  • 疫情期间STEMI入院率显著降低,但院内死亡率未显著增加。
  • 门球时间在疫情期间显著延长,需关注再灌注延迟。
  • 症状至首次医疗接触时间无显著差异,急性救治总体维持。

核心结论

  • 疫情期间STEMI入院率显著下降,但院内死亡率无显著增加。
  • 急性及时医疗护理在多数国家得以维持,长期死亡率数据待确定。

主要发现

  • 疫情期间STEMI总体入院率显著降低(IRR=0.789,95%CI 0.730-0.852,I2=77%,p<0.01)。
  • 院内死亡率与疫情前相比无显著差异(OR=1.178,95%CI 0.926-1.498,I2=57%,p=0.01)。
  • 症状至首次医疗接触时间相似(MD=33.4分钟,95%CI -10.2至77.1,I2=88%,p<0.01)。
  • 门球时间在疫情期间显著延长(MD=7.3分钟,95%CI 3.0-11.7,I2=95%,p<0.01)。

临床怎么用

  • 疫情期间需关注STEMI患者门球时间延长,优化再灌注流程。
  • 入院率下降原因未明,应加强公众教育以避免延误就医。

局限性

  • 入院率下降原因仍属推测,长期死亡率数据尚未确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Since the beginning of the SARS-CoV-2 outbreak, hospitals reported declining numbers of patients admitted with ST-segment elevation myocardial infarction (STEMI), indicating that the pandemic might keep patients from seeking urgent medical treatment. However, data on outcomes and mortality rates are inconsistent between studies. METHODS: A literature search and meta-analysis were performed on studies reporting the mortality of patients with STEMI admitted before and during the COVID-19 pandemic using PubMed, Embase and Web of Science. Additionally, prehospital and intrahospital delay times were evaluated. RESULTS: Outcomes of a total of 50 123 patients from 10 studies were assessed. Our study revealed that, despite a significant reduction in overall admission rates of patients with STEMI during the COVID-19 pandemic (incidence rate ratio=0.789, 95% CI 0.730 to 0.852, I2=77%, p<0.01), there was no significant difference in hospital mortality (OR=1.178, 95% CI 0.926 to 1.498, I2=57%, p=0.01) compared with patients with STEMI admitted before the outbreak. Time from the onset of symptoms to first medical contact was similar (mean difference (MD)=33.4 min, 95% CI -10.2 to 77.1, I2=88%, p<0.01) while door-to-balloon time was significantly prolonged in those presenting during the pandemic (MD=7.3 min, 95% CI 3.0 to 11.7, I2=95%, p<0.01). CONCLUSION: The significant reduction in admission of patients with STEMI was not associated with a significant increase of hospital mortality rates. The causes for reduced incidence rates remain speculative. However, the analysed data indicate that acute and timely medical care of these patients has been maintained during the pandemic in most countries. Long-term data on mortality have yet to be determined.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Rattka M, Dreyhaupt J, Winsauer C, et al. Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis. Heart. 2020. PMID: 33334863. doi:10.1136/heartjnl-2020-318360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。